DE69527524D1 - Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen - Google Patents

Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen

Info

Publication number
DE69527524D1
DE69527524D1 DE69527524T DE69527524T DE69527524D1 DE 69527524 D1 DE69527524 D1 DE 69527524D1 DE 69527524 T DE69527524 T DE 69527524T DE 69527524 T DE69527524 T DE 69527524T DE 69527524 D1 DE69527524 D1 DE 69527524D1
Authority
DE
Germany
Prior art keywords
lung
animal
hyperinflated
perfluorocoles
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69527524T
Other languages
English (en)
Inventor
Clark, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tenax Therapeutics Inc
Original Assignee
Synthetic Blood International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Blood International Inc filed Critical Synthetic Blood International Inc
Application granted granted Critical
Publication of DE69527524D1 publication Critical patent/DE69527524D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69527524T 1994-05-13 1995-05-12 Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen Expired - Lifetime DE69527524D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/242,310 US5674913A (en) 1994-05-13 1994-05-13 Method for assisting normal breathing in a mammal having a lung disorder
PCT/US1995/005993 WO1995031191A1 (en) 1994-05-13 1995-05-12 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders

Publications (1)

Publication Number Publication Date
DE69527524D1 true DE69527524D1 (de) 2002-08-29

Family

ID=22914268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527524T Expired - Lifetime DE69527524D1 (de) 1994-05-13 1995-05-12 Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen

Country Status (8)

Country Link
US (1) US5674913A (de)
EP (1) EP0758886B1 (de)
JP (1) JPH10505319A (de)
AT (1) ATE220901T1 (de)
AU (1) AU690277B2 (de)
CA (1) CA2190180C (de)
DE (1) DE69527524D1 (de)
WO (1) WO1995031191A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628930A (en) * 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
US5840767A (en) * 1995-12-01 1998-11-24 Synthetic Blood International, Inc. Perfluorocarbons for biological gas exchange and method
US6167887B1 (en) * 1997-11-21 2001-01-02 Synthetic Blood International, Inc. Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
US6562872B1 (en) * 2000-07-20 2003-05-13 Otkrytoe Aktsionernoe Obschestvo Naucho-Proizvodstven-Naya Firma “Perftoran” Emulsion of perfluoroorganic compounds for medical purposes, a process for the preparation thereof and methods for treating and preventing diseases with the use thereof
EP1365068B1 (de) * 2002-05-10 2008-05-07 The Procter & Gamble Company Geprägtes Tissue mit abstehenden Oberflächenfasern und Verfahren zu dessen Herstellung
US8535691B2 (en) * 2006-02-16 2013-09-17 Peach Technologies, LLC. Perflurochemical treatment process and apparatus
MX337857B (es) * 2006-05-15 2016-03-16 Univ Virginia Commonwealth Metodos y composiciones para la produccion y transporte controlados y sostenidos de peroxidos.
WO2008102563A1 (ja) 2007-02-23 2008-08-28 Next21 K.K. 血管攣縮の治療剤又は予防剤
EP2252333A4 (de) * 2008-02-13 2013-07-10 Oxygen Biotherapeutics Inc Wund- und gewebetherapeutika auf gasbasis
US8404752B2 (en) * 2008-07-18 2013-03-26 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
US20110086923A1 (en) * 2009-07-28 2011-04-14 Thompson Deborah P Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
US8513309B2 (en) 2010-10-01 2013-08-20 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
US4173654A (en) * 1977-01-03 1979-11-06 California Institute Of Technology Novel fluorohydrocarbons
AU650845B2 (en) * 1989-08-28 1994-07-07 K. Michael Sekins Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
WO1992019232A1 (en) * 1991-05-03 1992-11-12 Alliance Pharmaceutical Corp. Partial liquid breathing of fluorocarbons
US5146014A (en) * 1991-07-02 1992-09-08 Air Products And Chemicals, Inc. Perfluoroethyldimethyl cyclohexane
US5295953A (en) * 1992-05-26 1994-03-22 Hemagen/Pfc Method and apparatus for extracorporeal separation of fluorochemicals from whole blood of a patient

Also Published As

Publication number Publication date
US5674913A (en) 1997-10-07
WO1995031191A1 (en) 1995-11-23
EP0758886B1 (de) 2002-07-24
AU690277B2 (en) 1998-04-23
EP0758886A1 (de) 1997-02-26
ATE220901T1 (de) 2002-08-15
JPH10505319A (ja) 1998-05-26
CA2190180C (en) 2000-10-03
AU2549395A (en) 1995-12-05
CA2190180A1 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
DE69527524D1 (de) Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen
Downes The historical evolution, current status, and prospective development of pediatric critical care
Dörges et al. The laryngeal tube S: a modified simple airway device
Auerbach et al. Inadequate oxygenation and ventilation using the esophageal gastric tube airway in the prehospital setting
DE69432708D1 (de) Vorrichtung zur unterstützung bei kardiopulmonaler wiederbelebung
ATE144142T1 (de) Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
Koch et al. Bronchoscopic findings in post-obstructive pulmonary oedema
ATE143260T1 (de) Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen
Ratliff et al. Re-expansion Pulmonary Edema: A Rare But Life-Threatening Complication of a Commonly Performed Minor Surgical Procedure
WEST et al. Pulmonary function in cystic fibrosis of the pancreas
Idris Reassessing the need for ventilation during CPR
ASMUNDSSON et al. Complications of acute respiratory failure
Jones Essential intensive care
Glasser et al. The use of spontaneous ventilation with constant-positive airway pressure in the treatment of salt water near drowning
PUTMAN et al. Drowning: another plunge
Moore et al. Inhalational versus intravenous induction. A survey of emergency anaesthetic practice in the United Kingdom
Bailey et al. The role of continuous positive airway pressure during weaning from mechanical ventilation in cardiac surgical patients
Schoenstadt et al. A re-examination of the ventilating bronchoscope
REYNOLDS et al. Permissive hypercapnia and pressure-controlled ventilation as treatment of severe adult respiratory distress syndrome in a pediatric burn patient
DE69215568T2 (de) Verfahren zur Hemmung der Sauerstofftoxizität in den Lungen
Gerancher et al. Nasal BiPAP treats hypoxia from postobstructive pulmonary edema
Starr et al. Voices from the silent world of doctor and patient
Reynolds Respiratory Distress Syndrome: Methods of Mechanical Ventilation for Hyaline Membrane Disease
Bonica et al. Factors which affect ventilatory function during surgical pneumothorax
JOSHI et al. A CASE OF SEVERE INHALATIONAL THERMAL INJURIES

Legal Events

Date Code Title Description
8332 No legal effect for de